Mercaptopurine - Hepatology Indications

You are here : Home > Formulary Search > Mercaptopurine - Hepatology Indications

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Amber

Formulations :

Oral suspension
Tablets

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Associated Icons :

BNF SPC

Restrictions / Comments :

Documentation

Shared Care

Shared Care Request letter (Specialist to Primary Care Prescriber) - National Shared Care - Appendix 1

Shared Care

Shared Care Agreement Letter (Primary Care Prescriber to Specialist)- National Shared Care - Appendix 2

Shared Care

Shared Care Refusal Letter (Primary Care Prescriber to Specialist)- National Shared Care - Appendix 3

Shared Care

Azathioprine and 6MP for non-transplant indications -National shared care - update March 25

PAD Profile

ChemicalSubstance :

Mercaptopurine

Indication :

Hepatology Indications

Group Name :

Keywords :

RMOC, national shared care, autoimmune hepatitis, auto-immune hepatitis, 6-MP

Brand Names Include :

Puri-Nethol

Important Information :

Tablets and oral suspension are NOT bioequivalent. Do not confuse with mercaptamine (similar name).

Latest Additions Date From :

Latest Additions Date To :

Guidelines :

Supporting Documents :

Other Indications

Below are listed other indications that Mercaptopurine is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Hepatology Indications.

Committee Recommendations (1)

05 Oct 22 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) has agreed the National Shared Care Protocol for azathioprine and mercaptopurine for patients in adult services (non- transplant indications)